Login

Shopping Cart
Assessing, Managing, and Treating Suicidal Risk (virtual), October 15, 2021
E-mail this product to a friend E-mail this page to a friend


Previous  Up  Next" 
"Assessing, Managing, and Treating Suicidal Risk"(October 15, 2021)


Program times: 9:00am - 1:00pm PST, (Noon - 4pm EST)

Continuing Education: 4 hours

Psychologists: Specialized Training Services is approved by the American Psychological Association to sponsor continuing education for psychologists. Specialized Training Services maintains responsibility for these programs and their content.
LCSW's, MFT's and LPC's should check your licensing board to verify that hours by an APA approved provider are valid for your license.

Tuition and registration: Go to bottom of page

Cancellation Policy: Tuition, minus a $25.00 administrative fee, will be refunded to those providing a written notice of their intent to cancel no less than three weeks prior to the program registered for. With less than three weeks but more than two business days before the event, a written cancellation will result in a workshop credit, minus the $25.00 administrative fee, for use at another workshop within the next three years. With less than two business days notice, no refund or credit is provided under any circumstances. At any time another person may be substituted for the registrant without penalty.
Suicide continues to be a major cause of death in the United States, with 12 million Americans having serious suicidal thoughts every year. The onus of well informed care at universities, private mental health organizations, veterans care, even social service agencies is well documented. New innovations in the field have raised the standard of practice and expectations for successful treatment.



Programs

Assessing, Managing, and Treating Suicidal Risk

Suicide is the 10th leading cause of death and 12,000,000 adult Americans struggle with serious suicidal thoughts each year. Yet, problematically, many mental health clinicians are not sufficiently trained to work with patients who are suicidal. This often results an over-reliance on medications or brief inpatient admissions, neither of which has proven effective in decreasing suicidal ideation and/or behaviors. Fortunately, there are many recent innovations in the assessment and treatment of suicidal risk with evidence-based approaches that enable providers to work effectively with suicide risk on an outpatient basis using suicide-focused care. This presentation will highlight new models of understanding suicidal risk, innovations in clinical assessment, management of acute risk, and the effective treatment of suicidal risk. Using such approaches decreases exposure to malpractice liability and ensures ethical and competent treatment of this major public and mental health concern.


Workshop Content:
  • Innovations in the assessment and treatment of suicidal risk
  • New models of understanding suicidal risk
  • Management of acute suicidal risk
  • The effective treatment of suicidal risk
  • The Collaborative Assessment and Management of Suicidality (CAMS) approach to managing suicidal risk

Workshop Objectives:
  • Describe two new innovations in the assessment and treatment of suicidal risk
  • Identify two new models of understanding suicidal risk
  • Describe the standard of practice for the management of acute suicidal risk
  • List the components of effective treatment of suicidal risk
  • Describe the Collaborative Assessment and Management of Suicidality (CAMS) approach to managing suicidal risk

David Jobes, Ph.D., ABPP
David Jobes, Ph.D., ABPP
David A. Jobes, PhD, ABPP, is a professor of psychology, director of the suicide prevention laboratory, and associate director of clinical training at The Catholic University of America. Dr. Jobes is also an adjunct professor of psychiatry, School of Medicine, at Uniformed Services University. He has published six books and numerous peer-reviewed journal articles.

Dr. Jobes is a past president of the American Association of Suicidology (AAS) and he is the recipient of various awards for his scientific work including the 1995 AAS Shneidman award (early career contribution to suicidology), the 2012 AAS Dublin award (for career contributions in suicidology), and the 2016 AAS Linehan award (for suicide treatment research). He has been a consultant to the Centers for Disease Control and Prevention, the Institute of Medicine of the National Academy of Sciences, the National Institute of Mental Health, the Federal Bureau of Investigation, the Department of Defense, Veterans Affairs, and he now serves as a "highly qualified expert" to the US Army's intelligence and security command.

Dr. Jobes is a board member of the American Foundation for Suicide Prevention (AFSP) and serves on AFSP's Scientific Council and the Public Policy Council. He is a fellow of the American Psychological Association and is board certified in clinical psychology (American Board of Professional Psychology). Dr. Jobes maintains a private clinical and consulting practice in Washington, DC.


Location


This virtual seminar will be held on Zoom on your computer. One to two weeks prior to the program you will receive a Zoom link to access the program on October 15.

Registration



Assessing, Managing, and Treating Suicidal Risk: Tuition valid through September 15.
 $99.95 
Quantity:  

Assessing, Managing, and Treating Suicidal Risk: Tuition from September 16 - October 15.
 $109.95 
Quantity: